Sinovac Life Sciences has secured around US$500 million in funding to grow, expand capability and produce its COVID-19 vaccine candidate, CoronaVac...
Sinovac Confirms $500 Million Towards COVID-19 Vaccine Research
china
China Already Vaccinating Doctors and Border Workers for COVID-19
China's "high risk" professionals have been vaccinated with experimental COVID-19 vaccines since July. The Chinese National Health Commission revealed earlier this week these professionals include medical professionals working on the front lines and border officials.
Sinovac Announces Positive Preliminary PI/PII Results for “CoronaVac”
Sinovac, a Beijing-based company producing a vaccine for COVID-19 today announced their "CoronaVac" vaccine concluded preliminary Phase I/II trials showing "favorable immunogenicity and safety profiles."
COVID-19 Vaccines Coming in October, But Do We Have Enough Glass?
The South China Morning Post reported today some vaccines may become available as early as this autumn. Pfizer, meanwhile hinted their vaccine could come as early as October of this year.
Pace of Chinese COVID-19 Vaccine Concerns Some Experts
CanSino Biologics became known to the wider public for being the first manufacturer to begin work on a COVID-19 vaccine back in mid-March.
Stock Market Booms with COVID-19 Vaccine News
For key manufacturers, numbers are beginning to reflect the potential financial impact of vaccine development. Hopeful investors have surged the price of Moderna, whose press releases are dominating the news on vaccine development in the US. Recently....
Mass Production of Chinese COVID-19 Vaccine Begins
The two groups, The Beijing Institute of Biological Products and China National Biotec Group Co., are producing five variants of the vaccine with an estimated output of 100-120M vaccines per year.